The story appears on

Page A4

June 2, 2014

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » World

Cancer experts report ‘incredible’ progress

CANCER researchers say major progress is being made against a malady that kills more than 7 million people a year worldwide, but funding is short and many challenges remain.

Convincing people to eat healthy, exercise and quit smoking could drastically cut back on many preventable cancers, and a host of environmental factors that may lead to cancer have yet to be solved by science, experts say.

Still, researchers at the American Society of Clinical Oncology annual conference in Chicago say there is plenty of cause for optimism.

This year’s event, ASCO’s 50th, brings together 30,000 doctors, researchers and pharmaceutical agents from around the world.

“Scientifically the field of oncology has never been more exciting,” said Clifford Hudis, president of ASCO.

He cited new targeted therapies that take aim at the cellular functions of tumors, leading to progress against some cancers that are difficult to treat.

Also, immunotherapy is a field that uses a patient’s own immune system to attack tumors, and is showing promise against melanoma, leukemia and a handful of other cancers.

“We have made incredible progress in 50 years,” said Jyoti Patel, a cancer specialist at Northwestern University.

“What has been very exciting in the past several decades is the understanding of the biology of cancer, an effort of working together to catalogue the make-up and the molecular aberrations that distinguish cancer,” Patel said.

“In 2014 there will be almost 14 million cancer survivors in the US, and that number is expected to grow twofold over the next decades.”

The death rate from cancer has dropped about 1.5 percent annually over the past decade, and a person diagnosed with cancer today has a higher than 66 percent chance of being alive in five years.

“The scientific breakthroughs in cancer are occurring at a breathtaking pace and are translating into new drugs and devices that benefit patients more quickly than ever before,” said Richard Schilsky, ASCO’s chief medical officer.

However, he said this progress is in jeopardy due to a shortage of research funds, particularly from the National Institutes of Health, the largest government funder of US scientific research which last year had a budget of US$28.9 billion.

“The NIH budget has been flat for more than a decade and when adjusted for inflation ... is nearly 25 percent lower today than in 2003,” he said.

Hudis called for more focus on addressing both environmental and behavioral risk factors that drive up the cancer burden in the United States and around the world.

“While tobacco has long been the leading risk factor for cancer, obesity is a growing problem not only for the US but worldwide,” he said.

“Obesity is overtaking tobacco, at least in the US, as the leading modifiable risk factor for multiple cancers,” he said.




 

Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend